Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.
Research output: Contribution to journal › Article › peer-review
Standard Standard
Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. / Okoro, T.; Tafazal, S.; Longworth, S. et al.
In: Journal of Spinal Disorders and Techniques, Vol. 23, No. 1, 01.02.2010, p. 74-77.
In: Journal of Spinal Disorders and Techniques, Vol. 23, No. 1, 01.02.2010, p. 74-77.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Okoro, T, Tafazal, S, Longworth, S & Sell, P 2010, 'Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.', Journal of Spinal Disorders and Techniques, vol. 23, no. 1, pp. 74-77. https://doi.org/10.1097/BSD.0b013e31819afdc4
APA
Okoro, T., Tafazal, S., Longworth, S., & Sell, P. (2010). Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. Journal of Spinal Disorders and Techniques, 23(1), 74-77. https://doi.org/10.1097/BSD.0b013e31819afdc4
CBE
Okoro T, Tafazal S, Longworth S, Sell P. 2010. Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. Journal of Spinal Disorders and Techniques. 23(1):74-77. https://doi.org/10.1097/BSD.0b013e31819afdc4
MLA
Okoro, T. et al. "Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.". Journal of Spinal Disorders and Techniques. 2010, 23(1). 74-77. https://doi.org/10.1097/BSD.0b013e31819afdc4
VancouverVancouver
Okoro T, Tafazal S, Longworth S, Sell P. Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica. Journal of Spinal Disorders and Techniques. 2010 Feb 1;23(1):74-77. doi: 10.1097/BSD.0b013e31819afdc4
Author
RIS
TY - JOUR
T1 - Tumour necrosis [alpha]-blocking agent (Etanercept): A triple blind randomised controlled trial of its use in treatment of sciatica.
AU - Okoro, T.
AU - Tafazal, S.
AU - Longworth, S.
AU - Sell, P.
PY - 2010/2/1
Y1 - 2010/2/1
U2 - 10.1097/BSD.0b013e31819afdc4
DO - 10.1097/BSD.0b013e31819afdc4
M3 - Article
VL - 23
SP - 74
EP - 77
JO - Journal of Spinal Disorders and Techniques
JF - Journal of Spinal Disorders and Techniques
SN - 0301-620X
IS - 1
ER -